TY - JOUR
T1 - ESCRT-III-mediated membrane repair in cell death and tumor resistance
AU - Liu, Jiao
AU - Kang, Rui
AU - Tang, Daolin
N1 - Funding Information:
Acknowledgements We thank Dave Primm (Department of Surgery, University of Texas Southwestern Medical Center) for his critical reading of the paper. D.T. was supported by grants from the US National Institutes of Health (R01CA229275) and the American Cancer Society (Research Scholar Grant RSG-16-014-01-CDD [D.T.]).
Publisher Copyright:
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.
PY - 2021/2
Y1 - 2021/2
N2 - The plasma membrane is made of glycerophospholipids that separate the inner and outer parts of the cell. Under physiological conditions, it acts as a barrier and gatekeeper to protect cells from the environment. In pathological situations, it undergoes structural and functional changes, resulting in cell damage. Indeed, plasma membrane damage caused by various stresses (e.g., hypoxia, nutritional deficiencies, ultraviolet radiation, and chemotherapeutic agents) is one of the hallmarks of cell death. Phosphatidylserine exposure and plasma membrane blebbing usually occurs in apoptotic cells, while necrotic cells lose the integrity of the plasma membrane and thereby release intracellular damage-associated molecular patterns. In contrast, the endosomal sorting complex required for transport-III (ESCRT-III), an evolutionarily conserved protein complex with membrane fission machinery, plays a key role in the repair of damaged plasma membranes in various types of regulated cell death, such as necroptosis, pyroptosis, and ferroptosis. These emerging findings indicate that ESCRT-III is a potential target to overcome drug resistance during tumor therapy.
AB - The plasma membrane is made of glycerophospholipids that separate the inner and outer parts of the cell. Under physiological conditions, it acts as a barrier and gatekeeper to protect cells from the environment. In pathological situations, it undergoes structural and functional changes, resulting in cell damage. Indeed, plasma membrane damage caused by various stresses (e.g., hypoxia, nutritional deficiencies, ultraviolet radiation, and chemotherapeutic agents) is one of the hallmarks of cell death. Phosphatidylserine exposure and plasma membrane blebbing usually occurs in apoptotic cells, while necrotic cells lose the integrity of the plasma membrane and thereby release intracellular damage-associated molecular patterns. In contrast, the endosomal sorting complex required for transport-III (ESCRT-III), an evolutionarily conserved protein complex with membrane fission machinery, plays a key role in the repair of damaged plasma membranes in various types of regulated cell death, such as necroptosis, pyroptosis, and ferroptosis. These emerging findings indicate that ESCRT-III is a potential target to overcome drug resistance during tumor therapy.
UR - http://www.scopus.com/inward/record.url?scp=85087927235&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087927235&partnerID=8YFLogxK
U2 - 10.1038/s41417-020-0200-0
DO - 10.1038/s41417-020-0200-0
M3 - Editorial
C2 - 32669618
AN - SCOPUS:85087927235
SN - 0929-1903
VL - 28
JO - Cancer Gene Therapy
JF - Cancer Gene Therapy
IS - 1-2
ER -